BCL6 is required for differentiation of Ig-like transcript 3-Fc-induced CD8+ T suppressor cells

Journal of Immunology

Volumn 185, Issue 10, 2010, Pages 5714-5722

  Chang, Chih Chao ^a   Vlad, George ^a   D'agati, Vivette D ^a   Liu, Zhuoru ^a   Zhang, Qing Yin ^b   Witkowski, Piotr ^c   Torkamani, Ali A ^d   Stokes, Michael B ^a   Ho, Eric K ^a   Cortesini, Raffaello ^a   Suciu Foca, Nicole ^a  

^a NewYork Presbyterian Hospital   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; IG LIKE TRANSCRIPT 3 FC PROTEIN; IMMUNOGLOBULIN; PROTEIN BCL 6; RECOMBINANT ILT 3 FC PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGENICITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CELL STIMULATION; CONTROLLED STUDY; EFFECTOR CELL; EX VIVO STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; INJECTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; STREPTOZOCIN DIABETES; SUPPRESSOR CELL;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; DNA-BINDING PROTEINS; FEMALE; GENE KNOCKDOWN TECHNIQUES; GRAFT REJECTION; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOHISTOCHEMISTRY; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MICE, INBRED NOD; MICE, SCID; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, CELL SURFACE; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION; TRANSPLANTATION TOLERANCE;

EID: 78650652592     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001732     Document Type: Article

References (42)

1. Van Belle, T., and M. von Herrath. 2008. Immunosuppression in islet transplantation. J. Clin. Invest. 118:1625-1628.
2. Jaeger, C., M. D. Brendel, B. J. Hering, M. Eckhard, and R. G. Bretzel. 1997. Progressive islet graft failure occurs significantly earlier in autoantibody-positive than in autoantibody-negative IDDM recipients of intrahepatic islet allografts. Diabetes 46:1907-1910.
3. Stegall, M. D., K. J. Lafferty, I. Kam, and R. G. Gill. 1996. Evidence of recurrent autoimmunity in human allogeneic islet transplantation. Transplantation 61:1272-1274.
4. Riley, J. L., C. H. June, and B. R. Blazar. 2009. Human T regulatory cell therapy: take a billion or so and call me in the morning. Immunity 30:656-665.
5. Goudy, K. S., and R. Tisch. 2005. Immunotherapy for the prevention and treatment of type 1 diabetes. Int. Rev. Immunol. 24:307-326.
6. Bluestone, J. A., C. R. Mackay, J. J. O'Shea, and B. Stockinger. 2009. The functional plasticity of T cell subsets. Nat. Rev. Immunol. 9:811-816.
7. Zhou, L., M. M. Chong, and D. R. Littman. 2009. Plasticity of CD4+ T cell lineage differentiation. Immunity 30:646-655.
8. Kim-Schulze, S., L. Scotto, G. Vlad, F. Piazza, H. Lin, Z. Liu, R. Cortesini, and N. Suciu-Foca. 2006. Recombinant Ig-like transcript 3-Fc modulates T cell responses via induction of Th anergy and differentiation of CD8+ T suppressor cells. J. Immunol. 176:2790-2798.
9. Suciu-Foca, N., N. Feirt, Q. Y. Zhang, G. Vlad, Z. Liu, H. Lin, C. C. Chang, E. K. Ho, A. I. Colovai, H. Kaufman, et al. 2007. Soluble Ig-like transcript 3 inhibits tumor allograft rejection in humanized SCID mice and T cell responses in cancer patients. J. Immunol. 178:7432-7441.
10. Vlad, G., V. D. D'Agati, Q. Y. Zhang, Z. Liu, E. K. Ho, T. Mohanakumar, M. A. Hardy, R. Cortesini, and N. Suciu-Foca. 2008. Immunoglobulin-like transcript 3-Fc suppresses T-cell responses to allogeneic human islet transplants in hu-NOD/SCID mice. Diabetes 57:1878-1886.
11. Cella, M., C. Döhring, J. Samaridis, M. Dessing, M. Brockhaus, A. Lanzavecchia, and M. Colonna. 1997. A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J. Exp. Med. 185:1743-1751.
12. Brown, D., J. Trowsdale, and R. Allen. 2004. The LILR family: modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens 64:215-225.
13. Chang, C. C., R. Ciubotariu, J. S. Manavalan, J. Yuan, A. I. Colovai, F. Piazza, S. Lederman, M. Colonna, R. Cortesini, R. Dalla-Favera, and N. Suciu-Foca. 2002. Tolerization of dendritic cells by T (S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immunol. 3:237-243.
14. Manavalan, J. S., S. Kim-Schulze, L. Scotto, A. J. Naiyer, G. Vlad, P. C. Colombo, C. Marboe, D. Mancini, R. Cortesini, and N. Suciu-Foca. 2004. Alloantigen specific CD8+CD28-FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity. Int. Immunol. 16:1055-1068.
15. Adorini, L., N. Giarratana, and G. Penna. 2004. Pharmacological induction of tolerogenic dendritic cells and regulatory T cells. Semin. Immunol. 16:127-134.
16. Adorini, L., and G. Penna. 2009. Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists. Hum. Immunol. 70:345-352.
17. Penna, G., A. Roncari, S. Amuchastegui, K. C. Daniel, E. Berti, M. Colonna, and L. Adorini. 2005. Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1, 25-dihy-droxyvitamin D3. Blood 106:3490-3497.
18. Chang, C. C., Z. Liu, G. Vlad, H. Qin, X. Qiao, D. M. Mancini, C. C. Marboe, R. Cortesini, and N. Suciu-Foca. 2009. Ig-like transcript 3 regulates expression of proinflammatory cytokines and migration of activated T cells. J. Immunol. 182:5208-5216.
19. Delenstarr, G., H. Cattell, C. Chen, A. Dorsel, R. Kincaid, K. Nguyen, N. Sampas, S. Schidel, K. W. Shannon, T. U. Andrea, and P. K. Wolber. 2001. Estimation of the confidence limits of oligonucleotide array-based measurements of differential expression. SPIE Proc. Microarrays Optic Technol. Informatics 4266:120-131.
20. Liu, Z., S. Tugulea, R. Cortesini, S. Lederman, and N. Suciu-Foca. 1999. Inhibition of CD40 signaling pathway in antigen presenting cells by T suppressor cells. Hum. Immunol. 60:568-574.
21. Chang, C. C., B. H. Ye, R. S. Chaganti, and R. Dalla-Favera. 1996. BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor. Proc. Natl. Acad. Sci. USA 93:6947-6952.
22. Costoya, J. A. 2007. Functional analysis of the role of POK transcriptional repressors. Brief. Funct. Genomics Proteomics 6:8-18.
23. Patrussi, L., and C. T. Baldari. 2008. Intracellular mediators of CXCR4-dependent signaling in T cells. Immunol. Lett. 115:75-82.
24. Yu, D., S. Rao, L. M. Tsai, S. K. Lee, Y. He, E. L. Sutcliffe, M. Srivastava, M. Linterman, L. Zheng, N. Simpson, et al. 2009. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity 31:457-468.
25. Hsu, H. C., P. Yang, J. Wang, Q. Wu, R. Myers, J. Chen, J. Yi, T. Guentert, A. Tousson, A. L. Stanus, et al. 2008. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat. Immunol. 9:166-175.
26. Kassiotis, G., and A. O'Garra. 2009. Establishing the follicular helper identity. Immunity 31:450-452.
27. Arima, M., H. Toyama, H. Ichii, S. Kojima, S. Okada, M. Hatano, G. Cheng, M. Kubo, T. Fukuda, and T. Tokuhisa. 2002. A putative silencer element in the IL-5 gene recognized by Bcl6. J. Immunol. 169:829-836.
28. Kusam, S., L. M. Toney, H. Sato, and A. L. Dent. 2003. Inhibition of Th2 differentiation and GATA-3 expression by BCL-6. J. Immunol. 170:2435-2441.
29. Yoshida, K., A. Sakamoto, K. Yamashita, E. Arguni, S. Horigome, M. Arima, M. Hatano, N. Seki, T. Ichikawa, and T. Tokuhisa. 2006. Bcl6 controls granzyme B expression in effector CD8+ T cells. Eur. J. Immunol. 36:3146-3156.
30. Liu, Z., S. Tugulea, R. Cortesini, and N. Suciu-Foca. 1998. Specific suppression of T helper alloreactivity by allo-MHC class I-restricted CD8+CD28-T cells. Int. Immunol. 10:775-783.
31. Jiang, S., S. Tugulea, G. Pennesi, Z. Liu, A. Mulder, S. Lederman, P. Harris, R. Cortesini, and N. Suciu-Foca. 1998. Induction of MHC-class I restricted human suppressor T cells by peptide priming in vitro. Hum. Immunol. 59:690-699.
32. Vlad, G., R. Cortesini, and N. Suciu-Foca. 2005. License to heal: bidirectional interaction of antigen-specific regulatory T cells and tolerogenic APC. J. Immunol. 174:5907-5914.
33. Vlad, G., and N. Suciu-Foca. 2008. Resurgence or emergence of CD8+ Ts. Hum. Immunol. 69:679-680.
34. Qin, H., G. Vlad, R. Cortesini, N. Suciu-Foca, and J. S. Manavalan. 2008. CD8+ suppressor and cytotoxic T cells recognize the same human leukocyte antigen-A2 restricted cytomegalovirus peptide. Hum. Immunol. 69:776-780.
35. Pipkin, M. E., J. A. Sacks, F. Cruz-Guilloty, M. G. Lichtenheld, M. J. Bevan, and A. Rao. 2010. Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. Immunity 32:79-90.
36. Meiron, M., Y. Zohar, R. Anunu, G. Wildbaum, and N. Karin. 2008. CXCL12 (SDF-1alpha) suppresses ongoing experimental autoimmune encephalomyelitis by selecting antigen-specific regulatory T cells. J. Exp. Med. 205:2643-2655.
37. Aboumrad, E., A. M. Madec, and C. Thivolet. 2007. The CXCR4/CXCL12 (SDF-1) signalling pathway protects non-obese diabetic mouse from autoimmune diabetes. Clin. Exp. Immunol. 148:432-439.
38. Adorini, L., and G. Penna. 2009. Induction of tolerogenic dendritic cells by vitamin D receptor agonists. Handb. Exp. Pharmacol. 188:251-273.
39. Dinesh, R. K., B. J. Skaggs, A. La Cava, B. H. Hahn, and R. P. Singh. 2010. CD8+ Tregs in lupus, autoimmunity, and beyond. Autoimmun. Rev. 9:560-568.
40. Zozulya, A. L., S. Ortler, Z. Fabry, M. Sandor, and H. Wiendl. 2009. The level of B7 homologue 1 expression on brain DC is decisive for CD8 Treg cell recruitment into the CNS during EAE. Eur. J. Immunol. 39:1536-1543.
41. Joosten, S. A., K. E. van Meijgaarden, N. D. Savage, T. de Boer, F. Triebel, A. van der Wal, E. de Heer, M. R. Klein, A. Geluk, and T. H. Ottenhoff. 2007. Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4. Proc. Natl. Acad. Sci. USA 104:8029-8034.
42. Uss, E., S. L. Yong, B. Hooibrink, R. A. van Lier, and I. J. ten Berge. 2007. Rapamycin enhances the number of alloantigen-induced human CD103+CD8+ regulatory T cells in vitro. Transplantation 83:1098-1106.